465 related articles for article (PubMed ID: 21234260)
1. Metabolic syndrome and urologic diseases.
Gorbachinsky I; Akpinar H; Assimos DG
Rev Urol; 2010; 12(4):e157-80. PubMed ID: 21234260
[TBL] [Abstract][Full Text] [Related]
2. The impact of obesity on benign and malignant urologic conditions.
Chu KF; Rotker K; Ellsworth P
Postgrad Med; 2013 Jul; 125(4):53-69. PubMed ID: 23933894
[TBL] [Abstract][Full Text] [Related]
3. Urological aspects of the metabolic syndrome.
Hammarsten J; Peeker R
Nat Rev Urol; 2011 Aug; 8(9):483-94. PubMed ID: 21811224
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance is an independent predictor of severe lower urinary tract symptoms and of erectile dysfunction: results from a cross-sectional study.
Russo GI; Cimino S; Fragalà E; Privitera S; La Vignera S; Condorelli R; Calogero AE; Castelli T; Favilla V; Morgia G
J Sex Med; 2014 Aug; 11(8):2074-82. PubMed ID: 24836928
[TBL] [Abstract][Full Text] [Related]
5. Review of the pathophysiological aspects involved in urological disease associated with metabolic syndrome.
Sáenz Medina J; Carballido Rodríguez J
Actas Urol Esp; 2016 Jun; 40(5):279-87. PubMed ID: 26589347
[TBL] [Abstract][Full Text] [Related]
6. Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life.
Yassin DJ; Doros G; Hammerer PG; Yassin AA
J Sex Med; 2014 Jun; 11(6):1567-76. PubMed ID: 24712761
[TBL] [Abstract][Full Text] [Related]
7. Impact of phytotherapy on utility scores for 5 benign prostatic hyperplasia/lower urinary tract symptoms health states.
Dedhia RC; Calhoun E; McVary KT
J Urol; 2008 Jan; 179(1):220-5. PubMed ID: 18001791
[TBL] [Abstract][Full Text] [Related]
8. The relationships between metabolic syndrome, erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia.
Doğan Y; Uruç F; Aras B; Şahin A; Kıvrak M; Ürkmez A; Güner ND; Aydın S
Turk J Urol; 2015 Mar; 41(1):7-12. PubMed ID: 26328190
[TBL] [Abstract][Full Text] [Related]
9. Testosterone and Benign Prostatic Hyperplasia.
Rastrelli G; Vignozzi L; Corona G; Maggi M
Sex Med Rev; 2019 Apr; 7(2):259-271. PubMed ID: 30803920
[TBL] [Abstract][Full Text] [Related]
10. Association between Benign Prostatic Hyperplasia and Neutrophil-Lymphocyte Ratio, an Indicator of Inflammation and Metabolic Syndrome.
Ozer K; Horsanali MO; Gorgel SN; Horsanali BO; Ozbek E
Urol Int; 2017; 98(4):466-471. PubMed ID: 27464069
[TBL] [Abstract][Full Text] [Related]
11. Association of lower urinary tract symptom/benign prostatic hyperplasia measures with international index of erectile function 5 in middle-aged policemen of Korea and the role of metabolic syndrome and testosterone in their relationship.
Lee JH; Kwon H; Park YW
Urology; 2013 Nov; 82(5):1008-12. PubMed ID: 24041675
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis.
Gacci M; Corona G; Vignozzi L; Salvi M; Serni S; De Nunzio C; Tubaro A; Oelke M; Carini M; Maggi M
BJU Int; 2015 Jan; 115(1):24-31. PubMed ID: 24602293
[TBL] [Abstract][Full Text] [Related]
13. The Relationship between Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms and Mean Platelet Volume: The Role of Metabolic Syndrome.
Zhao S; Tang J; Shao S; Yan Y
Urol Int; 2016; 96(4):449-58. PubMed ID: 26745140
[TBL] [Abstract][Full Text] [Related]
14. Lower urinary tract symptoms, benign prostatic hyperplasia/benign prostatic enlargement and erectile dysfunction: are these conditions related to vascular dysfunction?
Shimizu S; Tsounapi P; Shimizu T; Honda M; Inoue K; Dimitriadis F; Saito M
Int J Urol; 2014 Sep; 21(9):856-64. PubMed ID: 24930630
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction.
Calogero AE; Burgio G; Condorelli RA; Cannarella R; La Vignera S
Aging Male; 2019 Mar; 22(1):12-19. PubMed ID: 29392976
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Syndrome and Nephrolithiasis Risk: Should the Medical Management of Nephrolithiasis Include the Treatment of Metabolic Syndrome?
DiBianco JM; Jarrett TW; Mufarrij P
Rev Urol; 2015; 17(3):117-28. PubMed ID: 26543426
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction.
García-Cruz E; Leibar-Tamayo A; Romero J; Piqueras M; Luque P; Cardeñosa O; Alcaraz A
J Sex Med; 2013 Oct; 10(10):2529-38. PubMed ID: 23898860
[TBL] [Abstract][Full Text] [Related]
18. Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit.
Vignozzi L; Morelli A; Sarchielli E; Comeglio P; Filippi S; Cellai I; Maneschi E; Serni S; Gacci M; Carini M; Piccinni MP; Saad F; Adorini L; Vannelli GB; Maggi M
J Endocrinol; 2012 Jan; 212(1):71-84. PubMed ID: 22010203
[TBL] [Abstract][Full Text] [Related]
19. Lower urinary tract symptoms/benign prostatic hypertrophy and vascular function: Role of the nitric oxide-phosphodiesterase type 5-cyclic guanosine 3',5'-monophosphate pathway.
Higashi Y
Int J Urol; 2017 Jun; 24(6):412-424. PubMed ID: 28332240
[TBL] [Abstract][Full Text] [Related]
20. The independent association of non-alcoholic fatty liver disease with lower urinary tract symptoms/benign prostatic hyperplasia and erectile function scores.
Eren H; Horsanali MO
BJU Int; 2019 Aug; 124(2):329-335. PubMed ID: 30900792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
